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Standard spiking
Batch prefiltration
Flush prefilter with water and 
buffer.  Perform prefiltration at 
constant pressure.  Filter at 
typical process times of ~2hrs 
to ensure comparable 
residence times for plugging 
agent removal
Batch virus filtration
Add virus spike to batch 
prefiltered product.  Filter 
spiked solution with 0.2 or 
0.45mm membranes.  Perform 
virus filtration, sample filtrate 
weight at regular time points
Introduction
Conventional virus filtration (VF) processes involve batch 
processing a uniform feed at uniform conditions (e.g. constant 
pressure).  Continuous VF processes can involve an elutiion
protein peak with a salt gradient under non-uniform pressure 
where standard spiking methodologies do not represent the 
manufacturing process as required by the ICH Q5A virus 
validation guidelines.  
This paper describes the development, qualification, and 
implementation of an inline spiking methodology that is suitable 
for validating continuous processes.
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Inline Qualification with salt spike
Salt spike improves sensitivity of concentration 
measurements:  2x difference in salt concentration 
(conductivity) corresponds to a 0.3 difference in log10 scales.
Run to run variability was <6%.  Sample syringe titer can be 
used as feed pool titer.  Sample syringe and filtrate within 
14% (0.07 log10 units or ~0 LRV).  The predicted 
filtrate/sample syringe titer within 9% (Hold control ~0 
LRV).  Well mixed solution so sample syringe is 
representative of cross section.  Mass balance closes & 
holdup volumes are negligible Summary
Inline spiking methodology:
 Improves filter throughputs
 More representative of manufacturing inline operation
 Demonstrates virus LRV comparable to standard 
spiking
 Consistent
 Relatively easy to operate
 Useful where proteins form plugging foulants
 Facilitates validation of linked processes
Herb Lutz (principal consulting engineer BSN process solutions)
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Feed & sample 




Inline qualification with prefiltration
mAb2 and Viresolve™ Pro spiked with 5% MMV
or 5% xMuLV
Figure 1:  Standard spiking system 
a) Batch prefiltration, b) Batch virus filtration 
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Viresolve Prefilter 5cm 2 
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Batch prefilter-> spike-> 
virus filter
Flush filters with water and 
buffer.  Add 0.2 mm filtered 
protein solution to the feed 
vessel and 0.2 mm filtered 
spiking solution to the feed 
syringe pump.  Pressurize 
feed vessel, open valves.  
Start syringe pump to 
continuously inject spike, 
mix with refiltered feed, 
sample, and feed to virus 
filter.  Measure filtrate 
weight vs time & calculate 
flow rate.  As the virus filter 
plugs and flow drops, slow 
down the syringe pump to 
















1   5% 0.68 0.028 0.024 0.028 
2   5% 0.68 0.029 0.025 0.029 
3   5% 0.68 0.026 0.024 0.026 
4 10% 0.68 0.070 0.063 0.064 
5 10% 0.68 0.069 0.057 0.064 











































MMV plugging due to protein.  xMuLV plugging due to 
protein+spike.  2-4x capacity increases with inline spiking (even 










MMV-inline 6.68 5.38 5.30 4.42
MMV-standard -- -- 5.68 4.80
xMuLV-inline 6.10 4.80 4.60 3.42
xMuLV-standard -- -- 4.48 3.30
Inline spiking shows comparable LRV to standard spiking.   
























operations are started 
before the previous 
steps are completed.
Virus filter or other 
clearance step sees 
variable operating 
feed parameters
ICH Q5A (1996)  
Measure virus removal 
using scaled down 
models that mirror large 
scale production to 
ensure that the virus 
removal results can be 




















elution to lag 
behind elution. 
MuLV elution from upstream CEX a) pH5, b) pH6
Herb.lutz@emdmillipore.com
